Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/1991
12/22/1991CA2045048A1 9-amino-2-phenylbicyclo[3.3.1] nonanes and 9-amino-2-phenylbicyclo [3.3.1] non-2-enes and drugs containing them
12/21/1991WO1991019474A1 Transdermal administration of buprenorphine
12/21/1991CA2085126A1 Transdermal administration of buprenorphine
12/20/1991CA2044786A1 Enantiomers of 2-tetrahydrofuran derivatives, intermediates, therefor, and their preparation
12/19/1991WO1991019493A1 Treatment of mood disorders with functional antagonists of the glycine/nmda receptor complex
12/19/1991CA2044797A1 N-benzyl-n'-phenyl- and phenalkyl-thioureas
12/19/1991CA2044736A1 Peptides derivatives, their preparation process and pharmaceutical compositions containing them
12/19/1991CA2043281A1 Benzopyran derivatives and heterocyclic analogs thereof as antiischemic agents
12/18/1991EP0462004A2 New use of modafinil
12/18/1991EP0461986A1 Derivatives of hexahydroazepines, procedure for their preparation and pharmaceutical compositions containing same
12/18/1991EP0461958A1 2-(aminoalkyl)-5-(arylalkyl)1,3-dioxanderivatives their production and their use in therapeutics
12/18/1991EP0461705A2 Agents for treating addiction to habit-forming drugs
12/18/1991EP0461696A1 Crystalline polypeptides with corticotropic activity
12/18/1991EP0461353A1 Biogenic amine uptake inhibitors
12/18/1991EP0461343A1 Cyclopropachromen derivatives
12/18/1991EP0461145A1 Magnesium folates, process for their preparation and pharmaceutical compositions
12/18/1991CN1015102B Process for preparation of novel quinaldinamide derivs
12/17/1991US5073671 1-(benzyl or pyridylmethyl)-4 or 5-aminomethyl-pyrrolidin-2-ones
12/17/1991US5073563 Alkoxycoumarins substituted by a heterocyclic radical, their preparation and therapeutic agents containing these compounds
12/17/1991US5073562 Antiinflammatory agents; leukotriene by antagonists
12/17/1991US5073560 Spiro-isoxazolidine derivatives as cholinergic agents
12/17/1991US5073557 Cognition activators, stimulants of central muscarinic acetylc holine receptors
12/17/1991US5073547 Dopamine pro-drug
12/17/1991US5073539 Transdermal administration of zwitterionic drugs
12/17/1991US5073375 Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof
12/17/1991CA1293249C 5-substituted 1,2,4-oxadiazole derivatives and preparation thereof
12/16/1991WO1991019719A1 Substituted naphthoxazines useful as dopaminergics
12/16/1991CA2083146A1 Substituted naphthoxazines useful as dopaminergics
12/16/1991CA2044699A1 Derivatives of 2-aminoalkyl-5-arylalkyl-1,3-dioxanes, their preparation and their therapeutic application
12/14/1991CA2044423A1 Agents for treating addiction to habit-forming drugs
12/14/1991CA2043497A1 Crystalline polypeptides
12/12/1991WO1991019009A1 The ciliary neurotrophic factor receptor
12/12/1991WO1991018982A1 Type ii interleukin-1 receptors
12/12/1991WO1991018981A2 Neurotropic growth factors comprising a homeobox peptide
12/12/1991WO1991018886A1 Compounds for the treatment of age-related memory impairment and other cognitive disorders
12/12/1991WO1991001958A3 11β-ARYL-GONA-4,9-DIEN-3-ONES
12/12/1991CA2043604A1 Pyridinylpiperazine derivatives
12/11/1991EP0461012A1 (1-Phenylpyrrolidin-2-yl)methylpiperazine derivatives, process for their preparation and their use in therapy
12/11/1991EP0460924A1 Dichloroaniline compound
12/11/1991EP0460846A1 Type II interleukin-1 receptors
12/11/1991EP0460720A2 A method of extruding liposomes
12/11/1991EP0460358A2 Agent for treating disorders from cerebral neuro-degeneration
12/11/1991EP0460153A1 NEW-$g(b)-CARBOLINS, PROCESS FOR PREPARING THEM AND THEIR USE IN DRUGS
12/11/1991EP0460078A1 Pharmaceutically active agents that impede amyloid formation in vivo
12/11/1991CN1056880A Pyrido (2,3-f) (1,4) thiazepines and pyrido (3,2-b) (1,5) benzothiazepines
12/11/1991CN1015057B Piperazine-heterocyclic compounds
12/11/1991CN1015055B Process for preparation of indole derivative and its modical use
12/10/1991US5071994 Intermediates for positive working photographic compounds, analgesics; anti-inflammatory agents
12/10/1991US5071985 Demethylation with sulfonic acid derivative in the presence of a sulfide
12/10/1991US5071875 Substituted 2-amidotetralins as melatonin agonists and antagonists
12/10/1991US5071874 L-carnitine magnesium citrate
12/10/1991US5071868 Beta blockers, vasodilators, therapy for glaucoma
12/10/1991US5071864 Aminoalkyl-substituted 2-aminothiazoles and therapeutic agents containing them
12/10/1991US5071859 N-substituted azaheterocyclic carboxylic acids and pharmaceutical uses
12/10/1991US5071858 Antipsychotic benzothiopyranylamines
12/10/1991US5071854 Hydroxytryptamine antagonists
12/10/1991US5071853 Amine-substituted hexahydroindeno(2,1-b)pyrroles, -indeno(2,1-c)pyridines or -indeno(2,1-d)azepines; cerebral ischemia or infarction
12/08/1991WO1991018897A1 Therapeutic heterocyclic compounds
12/08/1991WO1991018892A1 Benzothiazoline derivatives, process for their preparation and drugs containing same
12/08/1991WO1991018606A2 Orally active nonaddicting analgesics
12/08/1991CA2080005A1 Benzothiazole derivatives; process for preparing the same and therapeutic agents containing them
12/08/1991CA2064465A1 Orally active nonaddicting analgesics
12/08/1991CA2043981A1 ¬(1-arylpyrrolidin-2-yl)methyl| piperazine derivatives, their preparation and their application in therapeutics
12/07/1991CA2037188A1 Agent for treating disorders from cerebral neuro-degeneration
12/07/1991CA2037187A1 Cyclopropachromen derivatives
12/06/1991CA2043850A1 Dichloroaniline compound
12/05/1991WO1991018891A1 Aromatic pyrrolidine and thiazolidine amides
12/05/1991WO1991018605A1 Method for treating alcoholism with nalmefene
12/05/1991WO1991018597A1 Sigma binding site agents
12/05/1991CA2083500A1 Sigma binding site agents
12/04/1991EP0459830A1 Pharmacologically active CNS compounds
12/04/1991EP0459829A1 Pharmacologically active CNS compounds
12/04/1991EP0459819A2 Pharmacologically active CNS compound
12/04/1991EP0459702A1 Azole Derivatives
12/04/1991EP0459561A2 Dioxo-tetrahydroquinoline derivatives
12/04/1991EP0459256A1 Oxazolidinones with CNS-depressant activity
12/04/1991CN1056693A Pharmachutical compounds
12/04/1991CN1056686A Improved process for preparation of substituted indolone derivatives
12/04/1991CN1014993B 5-aryl-2,4-dialkyl-3h-1,2,4-triazole-3-thiones and their use as antidepressants
12/04/1991CN1014992B Quinazolidione and pyridopyrimidine dione and preparing method
12/03/1991US5070106 Compounds active on the cardiovascular system
12/03/1991US5070084 Adrenergic blocking agent
12/03/1991US5069909 Transdermal administration of buprenorphine
12/03/1991US5069904 Alzheimer's disease
12/03/1991CA1292841C Peptide derivatives, their production and use
12/03/1991CA1292742C Octahydro-oxazolo (4,5-g)quinolines
12/02/1991WO1991018899A1 3-amino-2-aryl quinuclidines, process for their preparation and pharmaceutical compositions containing them
12/02/1991WO1991018602A1 (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL
12/02/1991CA2043671A1 Pharmacologically active cns compounds
12/02/1991CA2043642A1 Pharmacologically active cns compounds
12/02/1991CA2043640A1 Pharmacologically active cns compounds
12/01/1991WO1991018607A1 Febarbamate for the treatment of cranial nervous disorders and encephalic circulation and metabolism disorders
12/01/1991CA2063736A1 Febarbamate for the treatment of cranial nervous disorders and encephalic circulation and metabolism disorders
12/01/1991CA2043367A1 Dioxo-tetrahydroquinoline derivatives
11/1991
11/30/1991CA2043424A1 Azole derivatives
11/30/1991CA2043317A1 Oxazolidinones
11/28/1991WO1991018016A1 Biologically active peptides containing d-2-alkyltryptophan
11/28/1991WO1991017980A1 Disulfide derivatives of mercaptoacylamino acids
11/28/1991WO1991017973A1 5H-DIBENZO(a,d)CYCLOHEPTENES AS MUSCARINIC RECEPTOR ANTAGONISTS
11/28/1991WO1991017772A1 Controlled release dopamine and its use to stimulate nerve fiber growth
1 ... 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 ... 1833